Grown Rogue International (GRUSF) Operating Margin (2018 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Operating Margin of 1.09% in Q1 2026, up 112.52% quarter-over-quarter from 8.7% in Q4 2025, and up 1101.0% on a YoY basis from 0.09% in Q1 2025.
Grown Rogue International (GRUSF) Operating Margin (2018 - 2026) Analysis & Trends
Grown Rogue International's Operating Margin history runs 9 years deep, the most recent figure standing at 1.09% for Q1 2026.
- In Q1 2026, Operating Margin rose 1101.0% year-over-year to 1.09%; the TTM figure through Mar 2026 stood at 16.65% (down 1701.0% YoY), while the FY2025 annual figure was 3.13%, up 290.0% from the prior year.
- Operating Margin was 1.09% for Q1 2026 at Grown Rogue International, up from 8.7% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 23.75% in Q4 2023 to a low of 15.7% in Q2 2025.
- Historically, Operating Margin has averaged 6.54% across 5 years, with a median of 11.71% in 2023.
- The sharpest annual moves came in 2022 and 2025: Operating Margin soared 10694 bps in 2022, then sank 2385 bps in 2025.
- A 5-year view of Operating Margin shows it stood at 13.04% in 2022, then declined by 10 bps to 11.71% in 2023, then tumbled by 98 bps to 0.23% in 2024, then plunged by 3960 bps to 8.7% in 2025, then surged by 113 bps to 1.09% in 2026.
- The last three Operating Margin figures came in at 1.09% (Q1 2026), 8.7% (Q4 2025), and 6.83% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 1.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09% |
| Dec 31, 2025 | -8.70% |
| Sep 30, 2025 | 6.83% |
| Jun 30, 2025 | -15.70% |
| Mar 31, 2025 | -9.92% |
| Dec 31, 2024 | 0.23% |
| Sep 30, 2024 | 13.97% |
| Jun 30, 2024 | 1.65% |
| Mar 31, 2024 | 13.93% |
| Dec 31, 2023 | 11.71% |
| Oct 31, 2023 | 23.75% |
| Jul 31, 2023 | 18.19% |
| Apr 30, 2023 | 13.77% |
| Jan 31, 2023 | 14.28% |
| Jan 31, 2022 | 13.04% |
| Oct 31, 2021 | 40.30% |
| Jul 31, 2021 | 23.62% |
| Apr 30, 2021 | -40.49% |
| Jan 31, 2021 | -93.90% |
| Jul 31, 2020 | -105.27% |